Cardinal Health

Cardinal Health

Yahoo Finance • yesterday

3 Momentum Stocks to Target This Week

3 Momentum Stocks to Target This Week Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions. While mo... Full story

Yahoo Finance • 2 days ago

CVS Health (CVS) Opens New Pharmacy Sites As Undervalued Narrative Holds

CVS Health (CVS) is expanding its pharmacy-focused format by opening nearly 20 smaller neighborhood locations across the US in 2026, including a new Roxbury site in the Boston area. Recent headlines around CVS Health have mixed signals fo... Full story

Yahoo Finance • 7 days ago

1 Healthcare Stock with Exciting Potential and 2 We Find Risky

1 Healthcare Stock with Exciting Potential and 2 We Find Risky Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as healthcare stocks... Full story

Yahoo Finance • 8 days ago

Disposable Medical Device Market to Reach USD 144.85 Billion by 2030, Growing at a CAGR of 4.9% – MarketsandMarkets™

MarketsandMarkets Research Pvt. Ltd. Delray Beach, FL , Oct. 05, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ projects the global disposable medical devices market to grow from USD 113.95 billion in 2025 to USD 144.85 billion by 2030, at a... Full story

Yahoo Finance • 8 days ago

How Extending CVS Distribution Through 2032 At Cardinal Health (CAH) Has Changed Its Investment Story

In October 2026, Cardinal Health announced it had entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032, maintaining the current scope of distribution services. This lon... Full story

Yahoo Finance • 12 days ago

Cardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS Health

DUBLIN, Ohio, Oct. 1, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that it has entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032, reflecting the... Full story

Yahoo Finance • 20 days ago

GE HealthCare (GEHC) is Down 28% and Wall Street is Starting to Buy. Is the Selloff Finally Over?

GE HealthCare Technologies Inc. (NASDAQ:GEHC) specializes in hospital imaging, including MRI, CT, and ultrasound machines, and the contrast agents required to interpret scans. Spun out of General Electric in early 2023, GE HealthCare trade... Full story

Yahoo Finance • 22 days ago

Cencora Highlights Specialty Growth, MSO Expansion and Walgreens Ties at Conference

Key Points Interested in Cencora, Inc.? Here are five stocks we like better. Specialty pharmaceuticals and MSOs are central to Cencora's growth strategy, with particular emphasis on retina and oncology practices. Management expects the MS... Full story

Yahoo Finance • 24 days ago

Cardinal Health Targets 13%-15% EPS Growth as Specialty Momentum Builds

Key Points Interested in Cardinal Health, Inc.? Here are five stocks we like better. Cardinal Health expects adjusted EPS to grow 13%-15% in fiscal 2027, driven mainly by operating-income growth across its business segments. The company a... Full story

Yahoo Finance • 24 days ago

Cardinal Health Sees Growth Normalize as Specialty, At-Home Investments Expand

Key Points Interested in Cardinal Health, Inc.? Here are five stocks we like better. Cardinal Health expects growth to normalize in fiscal 2027 after fiscal 2026 benefited from unusually strong specialty growth, customer onboarding, acqui... Full story

Yahoo Finance • 26 days ago

BTSG Faces $200M IRA Hit but Efficiency May Protect Profitability

BrightSpring Health Services' BTSG Home and Community Pharmacy business is facing a meaningful revenue setback from the Inflation Reduction Act (IRA), but the company's second-quarter performance suggests operational efficiency is helping... Full story

Yahoo Finance • 27 days ago

Can CAH Navigate IRA Pricing Changes Risk Without Margin Pressure?

Cardinal Health CAH has entered fiscal 2027 with regulatory changes remaining a key headwind for its Pharma business, particularly the impact of Inflation Reduction Act (IRA) pricing changes. In the fourth quarter, IRA-related WACC changes... Full story

Yahoo Finance • 28 days ago

Cardinal Health (CAH) Registers a Bigger Fall Than the Market: Important Facts to Note

Cardinal Health (CAH) ended the recent trading session at $232.36, demonstrating a -1.08% change from the preceding day's closing price. This change lagged the S&P 500's 0.45% loss on the day. Elsewhere, the Dow saw a downswing of 0.63%, w... Full story

Yahoo Finance • 29 days ago

AbbVie vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?

Choosing between a mature pharmaceutical giant and a speculative gene-editing pioneer requires a clear understanding of your personal risk tolerance. Do you prefer AbbVie (NYSE:ABBV) or CRISPR Therapeutics (NASDAQ:CRSP) in 2026? AbbVie is... Full story

Yahoo Finance • 29 days ago

McKesson Raises Outlook, Eyes Oncology Growth With Precision Medicine Deal

Key Points Interested in McKesson Corporation? Here are five stocks we like better. McKesson raised its full-year EPS guidance by $0.40 to $44.20–$45.00, reflecting approximately 13%–15% growth, or 15%–17% excluding certain prior-year ite... Full story

Yahoo Finance • 29 days ago

Amgen vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?

Choosing between Amgen (NASDAQ:AMGN) and Vertex Pharmaceuticals (NASDAQ:VRTX) requires balancing the stability of a diversified pharmaceutical giant against the high-growth, high-margin profile of a specialized biotechnology pioneer. Amge... Full story

Yahoo Finance • last month

Amgen vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?

Investors often face a choice between the stability of established giants and the high-stakes potential of clinical-stage innovators. Deciding between Amgen (NASDAQ:AMGN) and CRISPR Therapeutics (NASDAQ:CRSP) requires balancing immediate d... Full story

Yahoo Finance • last month

Amgen vs. Moderna: Which Healthcare Stock Is a Better Buy in 2026?

Should you bet on an established giant or a pipeline-driven innovator? This comparison examines Amgen (NASDAQ:AMGN) and Moderna (NASDAQ:MRNA) to see which stock is a better buy today. Amgen is a veteran in the drug manufacturing world, fo... Full story

Yahoo Finance • last month

Cardinal (CAH) Up 2.5% Since Last Earnings Report: Can It Continue?

It has been about a month since the last earnings report for Cardinal Health (CAH). Shares have added about 2.5% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings releas... Full story

Yahoo Finance • last month

Jim Cramer Picks J&J (JNJ) Over Eli Lilly (LLY) and Pfizer (PFE) Among These Healthcare Stocks

On September 3, a caller asked whether to rotate out of artificial intelligence stocks and add to Eli Lilly and Company (NYSE:LLY) rather than chase Johnson & Johnson (NYSE:JNJ) or Cardinal Health (NYSE:CAH). Mad Money host Jim Cramer said... Full story